Get to know our clinical trials
Validation of the sentinel lymph node technique in early ovarian cancer (Sentov II)
ESTE ESTUDIO CONSISTE EN LOCALIZAR EN EL MOMENTO DE LA OPERACIÓN EL GANGLIO CENTINELA, AUNQUE SE LE REALIZARÁ IGUALMENTE LA TÉCNICA ESTÁNDAR, ES DECIR EXTIRPACIÓN DE TODOS LOS GANGLIOS DE LA PELVIS Y PARAÓRTICOS, PARA EVALUAR ASÍ LA CONCORDANCIA DEL RESULTADO ENTRE AMBAS PRUEBAS DIAGNÓSTICAS (LA TÉCNICA DEL GANGLIO CENTINELA Y LA TÉCNICA ESTÁNDAR).
Technical Summary
- VALIDATION OF THE SENTINEL LYMPH NODE TECHNIQUE IN EARLY OVARIAN CANCER (SENTOV II)
- Code EudraCT: 2024-520189-67-00
- Protocol number: SENTOV II
- Promoter: Instituto de Investigación Sanitaria La Fe
- Molecule/Drug: Tecnecio 99
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
More information about this clinical trial
Information offered by the Spanish Registry of Clinical Studies
- Summary
- Information
- Calendar
- Headquarters
- Drugs
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.